William Vetter
Family Medicine · Nampa, IDNPI 1992775480
Payments from drug & device makers
Across 77 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$183
- Novartis$156
- AbbVie$146
- Pfizer$112
- AstraZeneca$103
- Mylan Specialty L.p.$94
- plus $473 from 14 others
What the payments were for
- Food & beverage$1,267100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $183 |
| Novartis | 9 | $156 |
| AbbVie(2 entities) | 8 | $146 |
| Pfizer | 7 | $112 |
| AstraZeneca | 6 | $103 |
| Mylan Specialty L.p. | 5 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $53 |
| Lilly USA, LLC | 4 | $53 |
| Bayer | 3 | $51 |
| Amgen(2 entities) | 3 | $49 |
| GSK | 3 | $45 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Sanofi-aventis U.S. LLC | 3 | $40 |
| Boehringer Ingelheim | 2 | $37 |
| Exact Sciences | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
How this compares
$1,267 in reported general payments places this provider in the 75th percentile of 803 family medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 186 | $152,571 |
| OzempicSemaglutide | 77 | $93,460 |
| FarxigaDapagliflozin Propanediol | 78 | $72,563 |
| JardianceEmpagliflozin | 59 | $61,349 |
| EntrestoSacubitril/Valsartan | 61 | $59,470 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $33,665 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 38 | $18,046 |
| TrulicityDulaglutide | 11 | $16,480 |
| XareltoRivaroxaban | 14 | $15,672 |
| MounjaroTirzepatide | 14 | $14,852 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $7,032 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 15 | $6,953 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $6,460 |
| Duloxetine Hcl | 200 | $5,544 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,384 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $112 | $152,571186 claims |
| Novo NordiskOzempic | $183 | $93,46077 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Stiolto Respimat | $37 | $86,348112 claims |
| AstraZenecaFarxiga | $103 | $72,56378 claims |
| NovartisEntresto | $156 | $59,47061 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $45 | $39,04950 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $53 | $31,33225 claims |
| Johnson & JohnsonXarelto | $16 | $15,67214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 803 family medicine providers in Idaho.
Other family medicine in Nampa
- Bryan PogueNampa$8K
- Trent GilesNampa$8K
- Kindra GallowayNampa$6K
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
- Flint PackerIdaho Falls$587K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.